Cardinal Health, Inc. (CAH) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail c...
Cardinal Health, Inc. (CAH) currently trades at a P/E ratio of 35.99 (historical range: 19.50–36.77, median: 25.04), placing it at the 96th percentile — expensive relative to its history, P/S ratio of 0.22 (range: 0.12–0.23, 96th percentile — expensive relative to its history), EV/EBITDA of 32.35 (range: 17.58–83.11, 57th percentile).
Over the historical period (2024-08-30 to 2026-08-28), Cardinal Health, Inc.'s P/E ratio has expanded by 27% over the observed period (from an average of 24.0 to 30.6).
Cardinal Health, Inc. appears overvalued relative to its own historical valuation range, trading at elevated multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 35.99 | 19.50 | 25.04 | 36.77 | 96th | expensive relative to its history |
| P/S Ratio | 0.22 | 0.12 | 0.17 | 0.23 | 96th | expensive relative to its history |
| EV/EBITDA | 32.35 | 17.58 | 31.33 | 83.11 | 57th | near its historical average |
| FCF Yield | 0.06 | 0.01 | 0.05 | 0.12 | 72th | below its historical average |